Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mRNA-1195.2
- Development stage
- Unknown
- Lead developer
- Moderna
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
mRNA-1195.2 is an investigational mRNA-based therapeutic vaccine developed by Moderna targeting the Epstein-Barr virus (EBV). It is one of two formulations of the mRNA-1195 candidate being evaluated in Phase 1 clinical trials. The vaccine is designed to address long-term complications associated with EBV infection, such as multiple sclerosis (MS) and post-transplant lymphoproliferative disorder (PTLD), in individuals who have already acquired the virus. mRNA-1195.2 incorporates the mRNA components of Moderna's prophylactic EBV vaccine candidate, mRNA-1189, along with additional mRNA sequences encoding latent EBV antigens to stimulate a broader immune response against the virus in its latent state.
- Other names
- Epstein-Barr Virus vaccine mRNA-1195.2
Beyond the preview
Go deeper on mRNA-1195.2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mRNA-1195.2.